Some people with SOD1-ALS experienced improvements in physical function and muscle strength after three years on Qalsody, an ...

Actor Eric Dane, who lives with ALS, has joined the board of directors of the U.S. nonprofit Target ALS, with an aim of ...

MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...

Our top 10 ALS news stories of 2025 feature actor Eric Dane’s advocacy and major research milestones in the field.

Columnist Dagmar Munn pens a letter to her younger self addressing early concerns about ALS, just after her diagnosis 15 years ago.

As columnist Kristin Neva reflects on 2025 and looks ahead to the new year, she finds hope even in the uncertainty of living with ALS.

NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...

Amyotrophic lateral sclerosis (ALS) is a progressive muscle-wasting condition that has no cure. Living with ALS and coming to terms with the diagnosis can be a challenge. It means adapting to a new ...

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the progressive loss of motor neurons, nerve cells that control the voluntary muscles. This leads to symptoms ...

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the progressive loss of motor neurons, nerve cells that control the voluntary muscles. This leads to overall ...

Health Canada has invited Neurosense Therapeutics to discuss the potential for giving conditional approval to PrimeC in treating amyotrophic lateral sclerosis (ALS), according to a company filing with ...